摘要
目的评价冠心病心衰患者采用美托洛尔联合曲美他嗪临床效果。方法选取我院2016年7月至2017年7月确诊为冠心病心衰的患者100例作为研究对象,采用随机数字表法的形式将其平均分为实验组与对照组,每组均50例。对照组行美托洛尔治疗法,实验组在此基础上联合采用曲美他嗪治疗法,对比分析两组临床疗效与治疗之后的心功能各项指标。结果实验组临床疗效与心功能各项指标均优于对照组,组间对比存在差异(P<0.05)。结论在冠心病心衰临床治疗过程中采用美托洛尔联合曲美他嗪治疗法,能够帮助患者提升临床疗效,改善心功能各项指标,值得进行推广。
Objective to evaluate the clinical effect of metoprolol combined with trimetazidine in patients with coronary heart failure.Methods a total of 100 cases of patients with coronary heart failure diagnosed in our hospital from July 2016 to July 2017 were selected as study objects.They were divided into experimental group and control group on average in the form of random number table,with 50 cases in each group.The control group was treated with metoprolol therapy,and the experimental group was combined with trimetazidine therapy on this basis to compare and analyze the clinical efficacy of the two groups and the indexes of cardiac function after treatment.Results the clinical efficacy and cardiac function indexes of the experimental group were superior to those of the control group, and there were differences between the two groups (P<0.05).Conclusion the use of metoprolol combined with trimetazidine in the clinical treatment of coronary heart failure can help patients improve clinical efficacy and improve the indicators of cardiac function,which is worth promoting.
作者
徐余田
曹江红
XU Yu-tian;CAO Jiang-hong(Linyi Lingang Economic Development Zone People's Hospital,Linyi,Shandong,276624)
出处
《智慧健康》
2018年第30期46-47,共2页
Smart Healthcare
关键词
冠心病心衰
美托洛尔
曲美他嗪
临床疗效
Coronary heart failure
Metoprolol
Trimetazidine
Clinical curative effect
